Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Scott Thomas, PhD

    TitleAssistant Researcher
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1450 Third St
    San Francisco CA 94158
    Phone415-476-5783
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California, San FranciscoPostdoctoral StudiesGraduate Division

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Terranova-Barberio M, Thomas S, Munster PN. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors. Immunotherapy. 2016 Jun; 8(6):705-19. PMID: 27197539.
        View in: PubMed
      2. Streib E, Blake D, Christmas AB, Clancy K, Cocanour C, Cooper C, Driscoll RP, Eastman AL, Ekeh AP, Gonzalez R, Hinsdale JG, Joseph K, Kuhls DA, Thomas SG, Cooper Z. American Association for the Surgery of Trauma statement on firearm injuries. J Trauma Acute Care Surg. 2016 Jun; 80(6):849. PMID: 27116407.
        View in: PubMed
      3. Park J, Thomas S, Munster PN. Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy. Epigenomics. 2015; 7(4):641-52. PMID: 26111034.
        View in: PubMed
      4. Thurn KT, Thomas S, Raha P, Qureshi I, Munster PN. Histone deacetylase regulation of ATM-mediated DNA damage signaling. Mol Cancer Ther. 2013 Oct; 12(10):2078-87. PMID: 23939379; PMCID: PMC3821775.
      5. Thomas S, Thurn KT, Raha P, Chen S, Munster PN. Efficacy of histone deacetylase and estrogen receptor inhibition in breast cancer cells due to concerted down regulation of Akt. PLoS One. 2013; 8(7):e68973. PMID: 23874830; PMCID: PMC3711340.
      6. Raha P, Thomas S, Munster PN. Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance. Epigenomics. 2011 Aug; 3(4):451-70. PMID: 22126205.
        View in: PubMed
      7. Thomas S, Thurn KT, Biçaku E, Marchion DC, Münster PN. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Breast Cancer Res Treat. 2011 Nov; 130(2):437-47. PMID: 21298336; PMCID: PMC3760725.
      8. Thurn KT, Thomas S, Moore A, Munster PN. Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Future Oncol. 2011 Feb; 7(2):263-83. PMID: 21345145; PMCID: PMC3127396.
      9. Thomas S, Munster PN. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy. Cancer Lett. 2009 Aug 8; 280(2):184-91. PMID: 19185986.
        View in: PubMed
      Scott's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP